Predictions
Siemens Healthineers AG
Start price
Target price
Perf. (%)
€52.60
19.02.22
19.02.22
€60.00
19.02.23
19.02.23
-4.94%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Infineon Technologies AG
Start price
Target price
Perf. (%)
€35.06
03.02.22
03.02.22
-
03.02.23
03.02.23
-17.00%
21.02.22
21.02.22
Could be very worthwhile Investment >20% year
Fair valuation
Leading role in innovation
Very small cyclical dependencies
Infineon Technologies AG
Start price
Target price
Perf. (%)
€35.08
03.02.22
03.02.22
-
03.02.23
03.02.23
-0.04%
03.02.22
03.02.22
Could be very worthwhile Investment >20% year
Fair valuation
Leading role in innovation
Very small cyclical dependencies
Infineon Technologies AG
Start price
Target price
Perf. (%)
€35.12
03.02.22
03.02.22
€40.00
03.02.23
03.02.23
2.71%
04.02.23
04.02.23
Could be worthwhile Investment >10% per year
Carl Zeiss Meditec AG
Start price
Target price
Perf. (%)
€147.00
01.02.22
01.02.22
€180.00
01.08.22
01.08.22
-3.71%
01.08.22
01.08.22
Could be very worthwhile Investment >20% year
Standard Investments for future growth
Siemens Healthineers AG
Start price
Target price
Perf. (%)
€57.02
31.01.22
31.01.22
-
31.01.23
31.01.23
1.68%
03.02.22
03.02.22
Infineon Technologies AG
Start price
Target price
Perf. (%)
€35.78
31.01.22
31.01.22
-
31.01.23
31.01.23
-1.97%
03.02.22
03.02.22
Could be very worthwhile Investment >20% year
Fair valuation
Leading role in innovation
Very small cyclical dependencies
Infineon Technologies AG
Start price
Target price
Perf. (%)
€34.69
25.01.22
25.01.22
-
25.01.23
25.01.23
3.16%
31.01.22
31.01.22
Could be very worthwhile Investment >20% year
Fair valuation
Leading role in innovation
Very small cyclical dependencies
Deutsche Telekom AG
Start price
Target price
Perf. (%)
€15.80
11.01.22
11.01.22
€10.00
11.01.23
11.01.23
27.56%
12.01.23
12.01.23
Infineon Technologies AG
Start price
Target price
Perf. (%)
€39.31
22.12.21
22.12.21
-
22.12.22
22.12.22
-11.75%
25.01.22
25.01.22
Could be very worthwhile Investment >20% year
Fair valuation
Leading role in innovation
Very small cyclical dependencies